← Browse by Condition
Medical Condition

heart transplantation

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for heart transplantation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — heart transplantation Clinical Trials

How many clinical trials are currently recruiting for heart transplantation?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for heart transplantation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for heart transplantation?
heart transplantation research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a heart transplantation clinical trial?
Eligibility criteria for heart transplantation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Fernando Bacal 1 trial
Fatebenefratelli Hospital 1 trial

Recruiting Clinical Trials

NCT05909150 Phase 2
Recruiting
Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
Enrollment
74 pts
Location
Brazil
Sponsor
Fernando Bacal
View Trial →
NCT05081115
Recruiting
Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Enrollment
10,000 pts
Location
Italy
Sponsor
Fatebenefratelli Hospital
View Trial →

Related Conditions

acute kidney injury (1) coronary artery disease (1) heart failure (1) hypertrophic cardiomyopathy (1) congenital heart disease (1) valvular heart disease (1) post chest radio chemiotherapy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology